BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Cipla Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500087
ISIN Demat
INE059A01026
Book Value (Rs)
397.3905511
NSE Symbol
CIPLA
Divident Yield %
1.04
Market Cap
(Rs In Cr.)
123,675
P/E (TTM)
25.69
EPS (TTM)
59.59
Face Value
(Rs)
2
Back
Cipla consolidated net profit rises 10.19% in the June 2025 quarter
25-Jul-25   Hrs IST

Net profit of Cipla rose 10.19% to Rs 1297.62 crore in the quarter ended June 2025 as against Rs 1177.64 crore during the previous quarter ended June 2024. Sales rose 3.20% to Rs 6837.04 crore in the quarter ended June 2025 as against Rs 6624.86 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales6837.046624.86 3
OPM %26.0125.90 -
PBDT2022.651858.04 9
PBT1769.931611.36 10
NP1297.621177.64 10

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)